Iovance Biotherapeutics, Inc. (IOVA) Financial Statements (2024 and earlier)

Company Profile

Business Address 825 INDUSTRIAL ROAD
SAN CARLOS, CA 94070
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:471,845504,410635,000307,081386,371145,373
Cash and cash equivalents231,73178,22967,32913,96982,152145,373
Short-term investments240,114426,181562,108293,112  
Other undisclosed cash, cash equivalents, and short-term investments   5,563 304,219 
Receivables      
Inventory, net of allowances, customer advances and progress billings      
Inventory      
Other undisclosed current assets7,2713,5461,1009,41289,0033,917
Total current assets:479,116507,956636,100316,493475,374149,290
Noncurrent Assets
Operating lease, right-of-use asset73,01568,98354,75610,695
Property, plant and equipment105,232100,93859,1598,5362,6832,450
Long-term investments and receivables  91,588    
Long-term investments  91,588    
Intangible assets, net (including goodwill)      
Intangible assets, net (excluding goodwill)      
Other noncurrent assets1891,78412,9183,4812,7643,633
Other undisclosed noncurrent assets6,4306,0845,5255,450  
Total noncurrent assets:184,866269,377132,35828,1625,4476,083
TOTAL ASSETS:663,982777,333768,458344,655480,821155,373
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities78,89884,14348,58731,83214,3989,892
Accounts payable26,60327,37713,51315,5672,7391,232
Accrued liabilities52,29556,76635,07416,26511,6598,660
Debt    7,252  
Other undisclosed current liabilities12,5875,0576,284   
Total current liabilities:91,48589,20054,87139,08414,3989,892
Noncurrent Liabilities
Long-term debt and lease obligation1,00066,47445,3754,248  
Long-term debt, excluding current maturities1,0001,000    
Liabilities, other than long-term debt71,859 11,7142,352230 
Deferred rent credit     230
Deferred income tax liabilities    
Other liabilities   11,7142,352  
Operating lease, liability71,85965,47445,3754,248
Other undisclosed noncurrent liabilities  (65,474)    
Total noncurrent liabilities:72,85966,47457,0896,600230 
Total liabilities:164,344155,674111,96045,68414,6289,892
Equity
Equity, attributable to parent, including:499,638621,659656,498298,971466,193145,481
Common stock8 6553
Additional paid in capital2,068,8671,794,6951,486,662869,354838,984394,651
Accumulated other comprehensive income (loss)(902)(601)19220(42) 
Accumulated deficit(1,568,338)(1,172,445)(830,193)(570,612)(372,760)(249,180)
Other undisclosed equity, attributable to parent3104467
Total equity:499,638621,659656,498298,971466,193145,481
TOTAL LIABILITIES AND EQUITY:663,982777,333768,458344,655480,821155,373

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues      
Cost of revenue      
Gross profit:      
Operating expenses(398,878)(342,703)(261,937)(206,872)(128,258)(92,877)
Operating loss:(398,878)(342,703)(261,937)(206,872)(128,258)(92,877)
Nonoperating income
(Investment Income, Nonoperating)
2,9854512,3569,3164,678813
Loss from continuing operations before income taxes:(395,893)(342,252)(259,581)(197,556)(123,580)(92,064)
Income tax benefit      
Loss from continuing operations:(395,893)(342,252)(259,581)(197,556)(123,580)(92,064)
Loss before gain (loss) on sale of properties:(342,252)(259,581)(197,556)(123,580)(92,064)
Net loss available to common stockholders, diluted:(395,893)(342,252)(259,581)(197,556)(123,580)(92,064)

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(395,893)(342,252)(259,581)(197,556)(123,580)(92,064)
Comprehensive loss:(395,893)(342,252)(259,581)(197,556)(123,580)(92,064)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(301)(620)(201)262(42)(29)
Comprehensive loss, net of tax, attributable to parent:(396,194)(342,872)(259,782)(197,294)(123,622)(92,093)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: